A 10-week program that combines cognitive behavioral therapy with cognitive training sharpens memory and helps patients cope ...

Factors including smoking status and relapse frequency are linked to increased risk of disease progression in MS, a ...

The effort will help the company assemble an investigational new drug application for Lucid-MS, which is expected by the end ...

MS-related cognitive impairments are often misperceived by others, columnist Desiree Lama writes, which can make a case of ...

Stem cells from donated placentas appear safe and may help ease secondary progressive MS, a small open-label Phase 1 clinical ...

Supervised at-home neural stimulation helped women with MS and cannabis use disorder decrease their cannabis intake and ...

Women with MS who have a close friend to confide in have better physical and mental health than those without this kind of ...

You should continue taking multiple sclerosis medication even when you feel fine, as stopping can risk worsening symptoms.

Non-pharmacological interventions, such as mindfulness and exercise, may improve sleep for MS patients, a meta-analysis of ...

The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

Three months of supplements with ellagic acid — an antioxidant — significantly eased fatigue, depression, and anxiety in MS ...